Search - tctmd.com

Displaying 241 - 260 of 327

Sort: Relevancy | Date

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

Presentation

Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin

Presenter: M. Zalesak

August 12, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

El Apixaban Beneficia a los Pacientes con FA con Independencia del Uso Previo de Warfarina

Jason Kahn

August 06, 2013

News Daily News

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Jason Kahn

August 06, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Caitlin E. Cox

July 25, 2013

News Daily News

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

L.A. McKeown

July 05, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

News Daily News

达比加群能够减少各种族心房纤维颤动患者的出血性卒中发生率

June 26, 2013

News Daily News

El Dabigatran Reduce los ACV Hemorrágicos en Pacientes con FA de Cualquier Grupo Étnico

June 26, 2013

News Daily News

Dabigatran Reduces Hemorrhagic Stroke in A-fib Patients Across Ethnic Groups

June 26, 2013

Presentation

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Presenter: M. Hori

June 21, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

Advertisement

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

El Apixaban Beneficia a los Pacientes con FA con Independencia del Uso Previo de Warfarina

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

达比加群能够减少各种族心房纤维颤动患者的出血性卒中发生率

El Dabigatran Reduce los ACV Hemorrágicos en Pacientes con FA de Cualquier Grupo Étnico

Dabigatran Reduces Hemorrhagic Stroke in A-fib Patients Across Ethnic Groups

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content